对喘患者吸入性皮质类固醇的元基因组和代谢组研究,有副作用
Igor Goryanin1,2,3,4,5, Anatoly Sorokin2,3, Meder Seitov3,4
1School of Informatics, University of Edinburgh, Edinburgh, UK.
Journal of integrative bioinformatics
|June 23, 2025
概括
在喘患者中研究吸入性皮质类固醇 (ICS) 的副作用,揭示了肠道微生物组和代谢组的改变. 托芬枯竭和其他代谢变化表明,潜在的饮食或益生菌干预措施,个性化喘管理.
科学领域:
- 胃肠病学 胃肠病学
- 肺部病理学 肺部病理学
- 微生物组研究 微生物组研究
背景情况:
- 用吸入性皮质类固醇 (ICS) 治疗的喘患者可能会出现不良副作用.
- 肠道微生物组和代谢组在这些副作用中的作用尚未完全理解.
研究的目的:
- 调查喘患者的肠道微生物组和代谢组差异,有或没有ICS相关的副作用.
- 确定ICS不良影响的关键微生物和代谢贡献者.
主要方法:
- 分析了来自24名参与者的便样本,分为三个队列:带有副作用的喘,没有副作用的喘和健康对照组.
- 利用下一代测序进行微生物组分析,以及LC-MS/MS用于代谢学.
- 雇佣了多业务因素分析 (MOFA) 和GSA-PRCC用于数据集成和相关性.
主要成果:
- 在患者组之间观察到细菌物种和代谢物的显著差异.
- 鉴定了托芬枯竭,改变的利诺酸盐和葡萄糖-1-酸盐水平作为可能导致副作用的因素.
- 多omics分析突出了与ICS不良影响相关的特定微生物和代谢途径.
结论:
- 肠道微生物组和代谢组的改变与喘患者的吸入性皮质类固醇副作用有关.
- 研究结果表明,饮食或益生菌干预可能有助于减轻这些副作用.
- 这项研究为针对肠道的个性化喘管理策略提供了基础.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
399
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
399
COPD: Management Using Bronchodilators and Corticosteroids
329
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
329
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
484
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
484
Inhaled Medications
414
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
414
Asthma: Pathogenesis and Management
618
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
618
Antiasthma Drugs: Methylxanthines
419
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
419


